Experimental DNA vaccine targets HPV to fight precancerous cervical cells
Disease control
Completed
This early-stage trial tested a DNA vaccine called NWRD08 in 9 women with high-grade cervical lesions caused by HPV types 16 or 18. The vaccine was given as a shot followed by a mild electrical pulse to help cells take it up. The main goal was to check safety and see if the vacci…
Phase: PHASE1 • Sponsor: Newish Technology (Beijing) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC